In Asia excluding Japan, organic revenue slipped 4% for the year. Performance improved in the second half, however, with organic growth of 2% in the third quarter and 1% in the fourth quarter, reversing the first-half downturn.
A patient living with diabetes who is also trying to quit smoking might reasonably choose a GLP-1 drug over another glucose-lowering medication, not because it is approved for smoking cessation, but because it may help them quit, a benefit that other diabetes drugs do not offer. Similarly, for people living with obesity who also struggle with alcohol, the potential for benefit beyond weight loss could be one more reason to consider a GLP-1 drug.
，详情可参考PDF资料
Названо число отправившихся на СВО фигурантов уголовных дел15:00。体育直播对此有专业解读
Последние новости